Table 3 The distribution of drug susceptibility according to the countries participating in the study
Country | Number of strains tested | R n (%) | INH-monoresistance n (%) | MDR-TBM n (%) | Other patterns n (%) | Dead n (%) | Resistance of strains from patiens dead n (%) |
|---|---|---|---|---|---|---|---|
Turkey | 69 | 12 (17.4) | 5 (7.2) | 3 (4.3) | 4 (5.8) | 9 (13.3) | 2 (22.2) |
Denmark | 25 | 1 (4.0) | 1 (4.0) | – | – | 8 (32.0) | 1 (12.5) |
Croatia | 19 | – | – | – | – | 9 (47.4) | – |
Serbia | 11 | 2 (18.2) | – | 2 (18.2) | – | 5 (45.5) | 1 (20.0) |
France | 9 | 4 (44.4) | 2 (22.2) | – | 2 (22.2) | 3 (33.3) | 2 (66.7) |
Hungary | 4 | – | – | – | – | – | – |
Slovenia | 3 | – | – | – | – | 1 (33.3) | – |
Albania | 1 | – | – | – | – | – | – |
Romania | 1 | 1 (100.0) | 1 (100.0) | – | – | – | – |
Total | 142 | 20 (14.1) | 9 (6.3) | 5 (3.5) | 6 (4.2) | 35 (24.6) | 6 (17.1) |